Vault-13

Birchview Capital, LP

BURLINGTON, VT · CIK 1618205 · 13F filing filed 2024-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$216.2m reported value -11.8% vs Q1 2024
60positions
67.6%in top 10
4 new 7 added 9 reduced 3 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BRISTOL-MYERS SQUIBB CO COM BMY BMY 1,376,436 $57.2m26.45% 26.45% ReducedShares held: Q3 2023 1.4m, Q4 2023 1.4m, Q1 2024 1.4m, Q2 2024 1.4m -30.8k -30,776 -2.2%
2 BIODESIX INC COM COM 11,237,289 $17.2m7.94% 7.94% AddedShares held: Q3 2023 10.5m, Q4 2023 10.5m, Q1 2024 10.5m, Q2 2024 11.2m +695.7k +695,680 6.6%
3 ELUTIA INC CL A COM ELUT ELUT 3,103,310 $15.4m7.12% 7.12% ReducedShares held: Q3 2023 3.3m, Q4 2023 3.3m, Q1 2024 3.3m, Q2 2024 3.1m -207.1k -207,058 -6.2%
4 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 84,480 $11.6m5.38% 5.38% ReducedShares held: Q3 2023 154.5k, Q4 2023 154.5k, Q1 2024 154.5k, Q2 2024 84.5k -70.0k -70,000 -45.3%
5 SILK RD MED INC COM SILK SILK 316,188 $8.5m3.96% 3.96% UnchangedShares held: Q3 2023 82.6k, Q4 2023 316.2k, Q1 2024 316.2k, Q2 2024 316.2k
6 PROTHENA CORP PLC SHS PRTA PRTA 407,148 $8.4m3.89% 3.89% AddedShares held: Q3 2023 339.1k, Q4 2023 339.1k, Q1 2024 339.1k, Q2 2024 407.1k +68.0k +68,000 20.1%
7 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 500,800 $8.1m3.76% 3.76% UnchangedShares held: Q3 2023 480.8k, Q4 2023 480.8k, Q1 2024 500.8k, Q2 2024 500.8k
8 OVINTIV INC COM OVV OVV 148,400 $7.0m3.22% 3.22% ReducedShares held: Q3 2023 168.4k, Q4 2023 168.4k, Q1 2024 168.4k, Q2 2024 148.4k -20.0k -20,000 -11.9%
9 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 20,000 $6.4m2.95% 2.95% ReducedShares held: Q3 2023 22.0k, Q4 2023 22.0k, Q1 2024 22.0k, Q2 2024 20.0k -2.0k -2,000 -9.1%
10 HARROW INC COM HROW HROW 300,000 $6.3m2.90% 2.90% UnchangedShares held: Q3 2023 300.0k, Q4 2023 300.0k, Q1 2024 300.0k, Q2 2024 300.0k
11 STOKE THERAPEUTICS INC COM STOK STOK 420,000 $5.7m2.63% 2.63% UnchangedShares held: Q3 2023 170.0k, Q4 2023 420.0k, Q1 2024 420.0k, Q2 2024 420.0k
12 PHREESIA INC COM PHR PHR 229,400 $4.9m2.25% 2.25% UnchangedShares held: Q3 2023 165.4k, Q4 2023 229.4k, Q1 2024 229.4k, Q2 2024 229.4k
13 CORCEPT THERAPEUTICS INC COM CORT CORT 148,000 $4.8m2.22% 2.22% AddedShares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 148.0k +48.0k +48,000 48.0%
14 QUIDEL CORP COM QDEL QDEL 135,238 $4.5m2.08% 2.08% AddedShares held: Q3 2023 130.4k, Q4 2023 130.4k, Q1 2024 130.4k, Q2 2024 135.2k +4.8k +4,832 3.7%
15 MASIMO CORP COM MASI MASI 30,560 $3.8m1.78% 1.78% UnchangedShares held: Q3 2023 30.6k, Q4 2023 30.6k, Q1 2024 30.6k, Q2 2024 30.6k
16 FOGHORN THERAPEUTICS INC COM FHTX FHTX 641,860 $3.7m1.71% 1.71% UnchangedShares held: Q3 2023 529.7k, Q4 2023 641.9k, Q1 2024 641.9k, Q2 2024 641.9k
17 EQUITRANS MIDSTREAM CORP COM ETRN ETRN 266,100 $3.5m1.60% 1.60% UnchangedShares held: Q3 2023 266.1k, Q4 2023 266.1k, Q1 2024 266.1k, Q2 2024 266.1k
18 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 96,000 $3.3m1.54% 1.54% UnchangedShares held: Q3 2023 76.0k, Q4 2023 96.0k, Q1 2024 96.0k, Q2 2024 96.0k
19 AXOGEN INC COM AXGN AXGN 394,000 $2.9m1.32% 1.32% AddedShares held: Q3 2023 346.0k, Q4 2023 346.0k, Q1 2024 346.0k, Q2 2024 394.0k +48.0k +48,000 13.9%
20 DOCGO INC COM DCGO DCGO 920,000 $2.8m1.32% 1.32% UnchangedShares held: Q3 2023 260.0k, Q4 2023 300.0k, Q1 2024 920.0k, Q2 2024 920.0k
21 ALKERMES PLC SHS ALKS ALKS 100,000 $2.4m1.11% 1.11% UnchangedShares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 100.0k
22 TRAVERE THERAPEUTICS INC COM TVTX TVTX 244,000 $2.0m0.93% 0.93% UnchangedShares held: Q3 2023 164.0k, Q4 2023 244.0k, Q1 2024 244.0k, Q2 2024 244.0k
23 ALPHATEC HLDGS INC COM NEW ATEC ATEC 176,000 $1.8m0.85% 0.85% UnchangedShares held: Q3 2023 160.0k, Q4 2023 176.0k, Q1 2024 176.0k, Q2 2024 176.0k
24 CASTLE BIOSCIENCES INC COM CSTL CSTL 68,000 $1.5m0.68% 0.68% AddedShares held: Q3 2023 0, Q4 2023 20.0k, Q1 2024 28.0k, Q2 2024 68.0k +40.0k +40,000 142.9%
25 EXXON MOBIL CORP COM XOM XOM 11,698 $1.3m0.62% 0.62% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 11.7k
26 PROGYNY INC COM PGNY PGNY 44,000 $1.3m0.58% 0.58% UnchangedShares held: Q3 2023 36.0k, Q4 2023 44.0k, Q1 2024 44.0k, Q2 2024 44.0k
27 10X GENOMICS INC CL A COM TXG TXG 60,000 $1.2m0.54% 0.54% UnchangedShares held: Q3 2023 42.0k, Q4 2023 60.0k, Q1 2024 60.0k, Q2 2024 60.0k
28 KINIKSA PHARMACEUTICALS LTD COM CL A COM CL A 60,000 $1.1m0.52% 0.52% UnchangedShares held: Q3 2023 60.0k, Q4 2023 60.0k, Q1 2024 60.0k, Q2 2024 60.0k
29 KALVISTA PHARMACEUTICALS INC COM KALV KALV 92,000 $1.1m0.50% 0.50% UnchangedShares held: Q3 2023 80.0k, Q4 2023 80.0k, Q1 2024 92.0k, Q2 2024 92.0k
30 CYTOKINETICS INC COM NEW CYTK CYTK 20,000 $1.1m0.50% 0.50% UnchangedShares held: Q3 2023 50.0k, Q4 2023 50.0k, Q1 2024 20.0k, Q2 2024 20.0k
31 APELLIS PHARMACEUTICALS INC COM APLS APLS 28,000 $1.1m0.50% 0.50% ReducedShares held: Q3 2023 36.0k, Q4 2023 36.0k, Q1 2024 36.0k, Q2 2024 28.0k -8.0k -8,000 -22.2%
32 HALOZYME THERAPEUTICS INC COM HALO HALO 20,000 $1.0m0.48% 0.48% UnchangedShares held: Q3 2023 20.0k, Q4 2023 20.0k, Q1 2024 20.0k, Q2 2024 20.0k
33 COHERUS BIOSCIENCES INC COM CHRS CHRS 540,000 $934.2k0.43% 0.43% UnchangedShares held: Q3 2023 0, Q4 2023 220.0k, Q1 2024 540.0k, Q2 2024 540.0k
34 KARYOPHARM THERAPEUTICS INC COM COM 939,664 $815.3k0.38% 0.38% UnchangedShares held: Q3 2023 1.1m, Q4 2023 939.7k, Q1 2024 939.7k, Q2 2024 939.7k
35 ARVINAS INC COM ARVN ARVN 30,000 $798.6k0.37% 0.37% UnchangedShares held: Q3 2023 30.0k, Q4 2023 30.0k, Q1 2024 30.0k, Q2 2024 30.0k
36 SAREPTA THERAPEUTICS INC COM SRPT SRPT 5,000 $790.0k0.37% 0.37% UnchangedShares held: Q3 2023 5.0k, Q4 2023 5.0k, Q1 2024 5.0k, Q2 2024 5.0k
37 XENON PHARMACEUTICALS INC COM XENE XENE 20,000 $779.8k0.36% 0.36% UnchangedShares held: Q3 2023 20.0k, Q4 2023 20.0k, Q1 2024 20.0k, Q2 2024 20.0k
38 ACCELERATE DIAGNOSTICS INC COM COM 650,478 $761.1k0.35% 0.35% UnchangedShares held: Q3 2023 450.5k, Q4 2023 450.5k, Q1 2024 650.5k, Q2 2024 650.5k
39 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 20,000 $753.4k0.35% 0.35% UnchangedShares held: Q3 2023 0, Q4 2023 20.0k, Q1 2024 20.0k, Q2 2024 20.0k
40 CULLINAN THERAPEUTICS INC COM CGEM CGEM 40,000 $697.6k0.32% 0.32% ReducedShares held: Q3 2023 50.2k, Q4 2023 50.2k, Q1 2024 50.2k, Q2 2024 40.0k -10.2k -10,228 -20.4%
41 NOVOCURE LTD ORD SHS NVCR NVCR 40,000 $685.2k0.32% 0.32% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 40.0k
42 AXSOME THERAPEUTICS INC COM AXSM AXSM 8,000 $644.0k0.30% 0.30% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 8.0k, Q2 2024 8.0k
43 KEROS THERAPEUTICS INC COM KROS KROS 14,000 $639.8k0.30% 0.30% UnchangedShares held: Q3 2023 14.0k, Q4 2023 14.0k, Q1 2024 14.0k, Q2 2024 14.0k
44 BLUEBIRD BIO INC COM COM 622,400 $612.6k0.28% 0.28% ReducedShares held: Q3 2023 910.4k, Q4 2023 642.4k, Q1 2024 642.4k, Q2 2024 622.4k -20.0k -20,000 -3.1%
45 AMICUS THERAPEUTICS INC COM FOLD FOLD 56,000 $555.5k0.26% 0.26% UnchangedShares held: Q3 2023 56.0k, Q4 2023 56.0k, Q1 2024 56.0k, Q2 2024 56.0k
46 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 14,730 $511.3k0.24% 0.24% UnchangedShares held: Q3 2023 0, Q4 2023 14.7k, Q1 2024 14.7k, Q2 2024 14.7k
47 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 80,000 $494.4k0.23% 0.23% AddedShares held: Q3 2023 40.0k, Q4 2023 40.0k, Q1 2024 40.0k, Q2 2024 80.0k +40.0k +40,000 100.0%
48 XENCOR INC COM XNCR XNCR 24,600 $465.7k0.22% 0.22% UnchangedShares held: Q3 2023 24.6k, Q4 2023 24.6k, Q1 2024 24.6k, Q2 2024 24.6k
49 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 80,000 $399.2k0.18% 0.18% UnchangedShares held: Q3 2023 0, Q4 2023 80.0k, Q1 2024 80.0k, Q2 2024 80.0k
50 G1 THERAPEUTICS INC COM GTHX GTHX 160,000 $364.8k0.17% 0.17% UnchangedShares held: Q3 2023 240.0k, Q4 2023 160.0k, Q1 2024 160.0k, Q2 2024 160.0k
51 INHIBRX BIOSCIENCES INC COM INBX INBX 24,220 $341.2k0.16% 0.16% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 24.2k
52 GOSSAMER BIO INC COM GOSS GOSS 276,352 $249.0k0.12% 0.12% UnchangedShares held: Q3 2023 418.2k, Q4 2023 276.4k, Q1 2024 276.4k, Q2 2024 276.4k
53 LIQUIDIA CORPORATION COM NEW LQDA LQDA 20,000 $240.0k0.11% 0.11% UnchangedShares held: Q3 2023 0, Q4 2023 40.0k, Q1 2024 20.0k, Q2 2024 20.0k
54 INFLARX NV COM IFRX IFRX 100,000 $174.0k0.08% 0.08% UnchangedShares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 100.0k
55 CABALETTA BIO INC COM CABA CABA 20,000 $149.6k0.07% 0.07% UnchangedShares held: Q3 2023 0, Q4 2023 20.0k, Q1 2024 20.0k, Q2 2024 20.0k
56 2SEVENTY BIO INC COMMON STOCK TSVT TSVT 35,666 $137.3k0.06% 0.06% ReducedShares held: Q3 2023 119.7k, Q4 2023 39.7k, Q1 2024 39.7k, Q2 2024 35.7k -4.0k -4,000 -10.1%
57 VENTYX BIOSCIENCES INC COM VTYX VTYX 57,600 $133.1k0.06% 0.06% UnchangedShares held: Q3 2023 52.8k, Q4 2023 57.6k, Q1 2024 57.6k, Q2 2024 57.6k
58 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 32,000 $130.9k0.06% 0.06% UnchangedShares held: Q3 2023 0, Q4 2023 32.0k, Q1 2024 32.0k, Q2 2024 32.0k
59 OUTSET MED INC COM OM OM 20,000 $77.0k0.04% 0.04% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 20.0k
60 PHOENIX BIOTECH ACQUISITION CLASS A COM CLASS A COM 25,944 $7.8k0.00% 0.00% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 25.9k, Q2 2024 25.9k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
INHIBRX INC INBX INBX 96,896 $3.4m96.9k shares
PIONEER NAT RES CO PXD PXD 7,600 $2.0m7.6k shares
YIELD10 BIOSCIENCE INC 37,500 $14.2k37.5k shares